Skip to main content
. 2023 Dec 1;7:e44705. doi: 10.2196/44705

Table 6.

Current contraceptive use in the United States—conventional modality survey (CMS) and app-based samples compared with the 2020 US National Survey of Family Growth (NSFG) 2017 to 2019 [38].

Responses CMS sample (n=2464), n (%) App-based sample (n=10,244), n (%) NSFG (aged 15-49 years, % of sample)
Current contraceptive users 1778 (72.2a,b) 7748 (75.6a,b) Weighted %c (47a)

Hormonal methods (total) 1184 (66.6c) 3033 (39.1c,d) 60c (28.4a)


LARCe methods 421 (23.7c) 1216 (15.7c) 26c (12.4a)



IUDf or IUSg 192 (10.8c,d) 827 (10.7c,d) 18c (8.4a)



Injection 143 (8c) 43 (0.6c) 4c (2a)



Implant 86 (4.8c) 346 (4.5c) 4c (2a)


Non-LARC methods 763 (42.9c) 1757 (22.5c) 34c (16a)



Pill 763 (42.9b,c) 1586 (20.5c,d) 30c (14a)



Ring or patch 0 (0) 171 (2.2c) 4c (2a)

Morning-after pill 24 (1.3c) 60 (0.8c) N/Ah

Nonhormonal methods (total) 570 (32.1c) 4147 (53.5b,c) 29c (13.8a)


Condoms 354 (19.9)c 1894 (24.4)c 18c (8.4a)


Natural methods 128 (7.2)c 1598 (20.6)b,c 11c (5.4a)


Copper IUD 31 (1.7)c 655 (8.5)c 0 (0)


Other methods 57 (3.2c,d) 568 (7.3)c,d 12c (5.6a)
Other responses 686 (27.8a) 2496 (24.4a) 53a

None used in the last 3 months 510 (20.7a,d) 1688 (16.5)a,d 34.7a

Female sterilization N/A N/A 18a

No answer or N/A 176 (7.1a) 808 (7.9a) N/A

aPercentage of survey sample.

bOverrepresentation compared with benchmark.

cPercentage of current contraceptive users (samples do not include sterilized respondents).

dUnderrepresentation compared with benchmark.

eLARC: long-acting reversible contraception.

fIUD: intrauterine device.

gIUS: intrauterine system.

hN/A: not applicable.